Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
JOYFINAC GEL is a topical branded generic medication marketed by JoY Pharma, a pharmaceutical company based in Bengaluru, India. It is a small molecule formulation designed for the localized treatment of pain and inflammation. The gel typically contains a combination of diclofenac diethylamine, methyl salicylate, menthol, and linseed oil. Diclofenac, the primary active ingredient, is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits the cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing the synthesis of pro-inflammatory prostaglandins. Methyl salicylate and menthol act as counter-irritants to provide a cooling sensation and further alleviate pain, while linseed oil contributes additional anti-inflammatory properties. JOYFINAC GEL is indicated for the relief of symptoms associated with musculoskeletal disorders such as arthritis, backache, sprains, and strains.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on JOYFINAC GEL.